Harbour BioMed Secures Patent Validity and Advances Legal Battle Against Biocytogen in China Harbour BioMed's patent validity is upheld by CNIPA amid an ongoing infringement lawsuit against Biocytogen, marking a significant legal win.

Harbour BioMed Secures Patent Validity and Advances Legal Battle Against Biocytogen in China #China #Shanghai #Harbour_BioMed #Biocytogen #HCAb_Patent